Meditation Apps for Stress Management in Black Women
Feasibility, Acceptability, and Preliminary Effects of Culturally-Adapted and Generic Meditation Apps for Stress Reduction in Middle-Aged Black Women
This randomized remote pilot study will evaluate the feasibility, acceptability, and preliminary effects of two meditation and mindfulness applications among approximately 40 Black women ages 35-64 experiencing moderate to high stress.
Participants will be randomly assigned in a 1:1 ratio to Exhale™, a culturally adapted meditation app designed for Black women, or Levelhead, a general mindfulness app. Participants will be asked to complete at least one session using their assigned app per day, lasting approximately 5 minutes or longer, at least 5 days per week for 4 weeks.
Participants will complete online questionnaires at baseline and after the 4-week intervention. Daily Remind messages and weekly study check-ins will support engagement. Outcomes include recruitment, retention, adherence, assessment completion, satisfaction, usability, perceived stress, race-based stress, sleep, depression, anxiety, cultural relevance, and brief participant feedback.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Interventio / Hoito
Yksityiskohtainen kuvaus
This study is a two-arm, randomized, fully remote pilot study comparing Exhale™, a culturally adapted meditation application designed for Black women, with Levelhead, a general science-based mindfulness application.
Approximately 40 Black women ages 35-64 who report moderate to high perceived stress will be enrolled. After eligibility screening, informed consent, and completion of baseline questionnaires through REDCap, participants will be randomized in a 1:1 ratio to Exhale™ or Levelhead using the REDCap randomization module.
Participants in both groups will be asked to complete at least one app-based meditation or mindfulness session per day, lasting approximately 5 minutes or longer, at least 5 days per week for 4 weeks. Participants may complete additional or longer sessions but will not be required to make up missed sessions. Daily Remind messages will ask participants whether they completed a session and the approximate number of minutes practiced. Weekly check-ins will provide study reminders and opportunities to request technical assistance.
Remote questionnaires will be administered at baseline and at the end of Week 4. Primary outcomes will assess feasibility and acceptability through recruitment, retention, adherence, assessment completion, satisfaction, and usability. Secondary outcomes will examine preliminary changes in perceived stress, race-based stress, sleep, depression, and anxiety. Cultural relevance and brief open-ended participant feedback will also be collected. Some participants may be invited to complete an optional brief remote exit interview.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Sunny Kim, PhD
- Puhelinnumero: 602-496-6789
- Sähköposti: sunny.kim@asu.edu
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Inclusion Criteria:
- Self-identifies as a Black or African American woman
- Ages 35-64 years
- Able to read and speak English
- Perceived Stress Scale-10 screening score greater than 14
- Has access to a smartphone or tablet with internet access
- Willing to complete remote baseline and post-intervention assessments
- Willing to attempt the assigned app-based practice for 4 weeks
- Willing to receive study communications
Exclusion Criteria:
- Regular use of meditation or mindfulness applications within the previous 6 months
- Any prior use of Exhale™
- Significant hearing impairment that prevents engagement with audio-based application content
- Self-reported difficulty navigating smartphone applications that would prevent participation
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Exhale™ Meditation App
Participants assigned to Exhale™ will use a culturally adapted meditation application designed for Black women.
Participants will be asked to complete at least one meditation session per day, lasting approximately 5 minutes or longer, at least 5 days per week for 4 weeks.
Participants will receive daily Remind messages, weekly study check-ins, and remote technical support as needed.
|
A culturally adapted meditation application designed for Black women that provides guided meditation and mindfulness content addressing stress, rest, grounding, self-care, and culturally relevant experiences.
Participants will manually select sessions and complete approximately 5 minutes or longer of practice at least 5 days per week for 4 weeks.
|
|
Active Comparator: Levelhead Mindfulness App
Participants assigned to Levelhead will use a general science-based mindfulness application.
Participants will be asked to complete at least one mindfulness session per day, totaling approximately 5 minutes or longer, at least 5 days per week for 4 weeks.
Participants will receive daily Remind messages, weekly study check-ins, and remote technical support as needed.
|
A general science-based mindfulness application that provides brief lessons addressing topics such as stress, focus, gratitude, and well-being.
Participants will complete approximately 5 minutes or longer of mindfulness practice at least 5 days per week for 4 weeks.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Participant Retention Rate at Week 4
Aikaikkuna: Baseline through Week 4
|
Percentage of enrolled participants who complete the 4-week intervention and post-intervention assessment.
The feasibility benchmark is greater than 75%.
|
Baseline through Week 4
|
|
Percentage of Eligible Individuals Who Consent and Enroll
Aikaikkuna: From recruitment opening through enrollment of the final participant, up to 6 months.
|
Recruitment rate will equal the number of eligible individuals who consent and enroll divided by the total number determined eligible, multiplied by 100.
The feasibility benchmark is greater than 70%.
|
From recruitment opening through enrollment of the final participant, up to 6 months.
|
|
Percentage of Recommended Practice Days Completed
Aikaikkuna: During the 4-week intervention
|
Adherence will be calculated from participant self-reports as completed practice days divided by 20 recommended practice days, multiplied by 100.
The benchmark is greater than 75%.
|
During the 4-week intervention
|
|
Assessment Completion Rate
Aikaikkuna: Baseline and Week 4
|
Percentage of expected baseline and post-intervention questionnaires completed by enrolled participants.
The benchmark is greater than 75%.
|
Baseline and Week 4
|
|
Participant Satisfaction With Assigned App
Aikaikkuna: Week 4
|
Satisfaction will be measured with the assigned-app satisfaction questionnaire.
Items are rated from 1 to 5, with higher scores indicating greater satisfaction.
Results will be summarized overall and by intervention arm.
|
Week 4
|
|
Assigned-App Usability Measured by the System Usability Scale
Aikaikkuna: Week 4
|
The 10-item System Usability Scale produces a total score from 0 to 100.
Higher scores indicate better perceived usability.
|
Week 4
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Perceived Stress Scale-10 Score
Aikaikkuna: Baseline to Week 4
|
The PSS-10 contains 10 items and produces a total score from 0 to 40.
Higher scores indicate greater perceived stress.
Change from baseline will be reported overall and by arm.
|
Baseline to Week 4
|
|
Change in Index of Race-Related Stress-Brief Score
Aikaikkuna: Baseline to Week 4
|
The 22-item IRRS-B produces a total score from 0 to 88.
Higher scores indicate greater race-related stress.
Change from baseline will be reported overall and by arm.
|
Baseline to Week 4
|
|
Change in POMS-SF Depression Subscale Score
Aikaikkuna: Baseline to Week 4
|
The six-item depression subscale produces a score from 0 to 24.
Higher scores indicate greater depressive mood disturbance.
|
Baseline to Week 4
|
|
Change in POMS-SF Tension/Anxiety Subscale Score
Aikaikkuna: Baseline to Week 4
|
The six-item tension/anxiety subscale produces a score from 0 to 24.
Higher scores indicate greater tension or anxiety.
|
Baseline to Week 4
|
|
Change in Insomnia Severity Index Score
Aikaikkuna: Baseline to Week 4
|
The seven-item Insomnia Severity Index produces a total score from 0 to 28.
Higher scores indicate more severe insomnia symptoms.
|
Baseline to Week 4
|
Muut tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Participant-Reported Cultural Relevance and App Feedback
Aikaikkuna: Week 4 and, when applicable, within approximately 1 week after Week 4
|
Cultural relevance, perceived usefulness, barriers, benefits, and recommendations will be assessed through post-intervention items and brief open-ended feedback.
Optional remote interviews may provide additional qualitative feedback.
|
Week 4 and, when applicable, within approximately 1 week after Week 4
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- STUDY00023706
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .